Vertebrobasilar Disease
NEJM 352:2618-2626, Savitz,S.I.&Caplan,L.R., 2005
The Efficacy & Safety of Ticlopidine & Aspirin in Non-Whites:Subgroup from Ticlopidine Aspirin Stroke Study
Neurol 43:27-31, Weisberg,L.A., 1993
High-Density Lipoprotein Cholesterol and Ischemic Stroke in the Elderly
JAMA 285:2729-2735, Sacco,R.L.,et al, 2001
Barriers to Acute Stroke Therapy and Stroke Prevention in Mexican Americans
Stroke 32:1360-1364, Morgenstern,L.B.,et al, 2001
Treatment with Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients with Ischemic Stroke Treated in Community Hospitals
Stroke 32:1832-1839,1840, Reed,S.D.,et al, 2001
Leisure-Time Physical Activity and Ischemic Stroke Risk, The Northern Manhattan Stroke Study
Stroke 29:380-387, Sacco,R.L.,et al, 1998
Clinical Features of Moyamoya Disease in the United States
Stroke 29:1347-1351, Chiu,D.,et al, 1998
Racial Variations in the Rates of Carotid Angiography and Endarterectomy in Patients with Stroke and TIA
Arch Int Med 153:2781-2786, Oddone,E.Z.,et al, 1993